全文获取类型
收费全文 | 2364篇 |
免费 | 325篇 |
国内免费 | 137篇 |
专业分类
化学 | 2305篇 |
力学 | 14篇 |
综合类 | 18篇 |
数学 | 97篇 |
物理学 | 392篇 |
出版年
2024年 | 8篇 |
2023年 | 56篇 |
2022年 | 339篇 |
2021年 | 425篇 |
2020年 | 234篇 |
2019年 | 112篇 |
2018年 | 76篇 |
2017年 | 103篇 |
2016年 | 156篇 |
2015年 | 153篇 |
2014年 | 136篇 |
2013年 | 190篇 |
2012年 | 131篇 |
2011年 | 92篇 |
2010年 | 70篇 |
2009年 | 87篇 |
2008年 | 70篇 |
2007年 | 65篇 |
2006年 | 52篇 |
2005年 | 39篇 |
2004年 | 22篇 |
2003年 | 34篇 |
2002年 | 24篇 |
2001年 | 16篇 |
2000年 | 19篇 |
1999年 | 22篇 |
1998年 | 13篇 |
1997年 | 20篇 |
1996年 | 15篇 |
1995年 | 12篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 7篇 |
1991年 | 5篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 4篇 |
1981年 | 1篇 |
排序方式: 共有2826条查询结果,搜索用时 734 毫秒
51.
目的研究大黄素是否可增强5AzA-cdR对胰腺癌Panc1细胞抑癌基因p16、RASSF1A的去甲基化作用。方法采用细胞增殖实验检测不同浓度大黄素对Panc1细胞的生长抑制情况,焦磷酸盐测序PCR(BSP)分别检测大黄素、5AzA-cdR及大黄素联合5AzA-cdR对Panc1细胞抑癌基因p16、RASSF1A甲基化状态的影响,并用荧光定量PCR(FQ-PCR)和Westernblot分别检测p16、RASSF1A及甲基转移酶DNMT1、DNMT3a在mRNA和蛋白水平的表达情况。结果大黄素以时间和浓度梯度依赖性抑制Panc1细胞生长。BSP结果显示大黄素具有微弱的去甲基化作用,5AzA-cdR具有一定程度的去甲基化作用,当两者联用时,去甲基化作用更加显著;FQ-PCR和Westernblot结果显示大黄素与5AzA-cdR联用时,p16、RASSF1A的表达水平均较空白对照明显增高(均P<0.05),DNMT1、DNMT3a的表达水平均较空白对照明显降低(均P<0.05)。结论大黄素与5AzA-cdR联用可通过降低DNMT1和DNMT3a的表达水平来增强5AzA-cdR对胰腺癌抑癌基因p16、RASSF1A的去甲基化作用。 相似文献
52.
Dr. Sumith A. Kularatne Vishal Deshmukh Dr. Marco Gymnopoulos Dr. Sandra L. Biroc Dr. Jinming Xia Shailaja Srinagesh Dr. Ying Sun Dr. Ning Zou Dr. Mark Shimazu Dr. Jason Pinkstaff Dr. Semsi Ensari Nick Knudsen Anthony Manibusan Dr. Jun Y. Axup Dr. Chan Hyuk Kim Prof. Vaughn V. Smider Dr. Tsotne Javahishvili Prof.Dr. Peter G. Schultz 《Angewandte Chemie (International ed. in English)》2013,52(46):12101-12104
53.
In Situ Proteome Profiling and Bioimaging Applications of Small‐Molecule Affinity‐Based Probes Derived From DOT1L Inhibitors 下载免费PDF全文
Biwei Zhu Dr. Hailong Zhang Sijun Pan Chenyu Wang Dr. Jingyan Ge Prof. Dr. Jun‐Seok Lee Prof. Dr. Shao Q. Yao 《Chemistry (Weinheim an der Bergstrasse, Germany)》2016,22(23):7824-7836
DOT1L is the sole protein methyltransferase that methylates histone H3 on lysine 79 (H3K79), and is a promising drug target against cancers. Small‐molecule inhibitors of DOT1L such as FED1 are potential anti‐cancer agents and useful tools to investigate the biological roles of DOT1L in human diseases. FED1 showed excellent in vitro inhibitory activity against DOT1L, but its cellular effect was relatively poor. In this study, we designed and synthesized photo‐reactive and “clickable” affinity‐based probes (AfBPs), P1 and P2 , which were cell‐permeable and structural mimics of FED1 . The binding and inhibitory effects of these two probes against DOT1L protein were extensively investigated in vitro and in live mammalian cells (in situ). The cellular uptake and sub‐cellular localization properties of the probes were subsequently studied in live‐cell imaging experiments, and our results revealed that, whereas both P1 and P2 readily entered mammalian cells, most of them were not able to reach the cell nucleus where functional DOT1L resides. This offers a plausible explanation for the poor cellular activity of FED1 . Finally with P1 / P2 , large‐scale cell‐based proteome profiling, followed by quantitative LC‐MS/MS, was carried out to identify potential cellular off‐targets of FED1 . Amongst the more than 100 candidate off‐targets identified, NOP2 (a putative ribosomal RNA methyltransferase) was further confirmed to be likely a genuine off‐target of FED1 by preliminary validation experiments including pull‐down/Western blotting (PD/WB) and cellular thermal shift assay (CETSA). 相似文献
54.
Structure‐cytotoxicity relationship of di?/tri‐organotin(IV) derivatives of mandelic acid ( 1 – 4 ), L‐proline ( 5 – 7, 15, 16 ), and mixed ligand complexes of latter with 1,10‐phenanthroline ( 8 – 14 ) investigated on the basis of MTT assay against human cancer cell lines, viz. MCF‐7 (mammary cancer), HepG2 (liver cancer) and PC‐3 (prostate cancer) in vitro indicated that all complexes except methyl‐ and octyl‐ analogues displayed potential cytotoxicity. The most active one is dibutyltin(IV) mandelate ( 2 ) exhibiting IC50 2.03 ± 0.40, 0.98 ± 0.23 and 3.86 ± 1.68 μM against MCF‐7, HepG2 and PC‐3, respectively, which is ≈ 15 and 2.5 times against MCF‐7, 20 and 5 times against HepG2 and 5 and ≈ 3 times against PC‐3 more cytotoxic than cis‐platin and 5‐fluorouracil, respectively. Diorganotin(IV) derivatives of mandelic acid are more cytotoxic than triorganotin analogues. Organotin(IV) derivatives of L‐proline (except Bu3Sn(Pro) 16 ) are less cytotoxic than those of mandelic acid but their cytotoxicity is enhanced by complexion with 1,10‐phenanthroline. This may be due to the structural planarity and extended π system of 1,10‐phenanthroline which facilitates their transportation across the cell membrane and enhances the possibility of DNA intercalation over the planar L‐proline ring, and eventually, their DNA binding affinity so as to interfere with the cellular functions of DNA leading to apoptosis. Various biophysical experiments such as DNA fragmentation, acridine orange and comet assays, and flow cytometry assay using annexin V–fluorescein isothiocyanate (FITC) and propidium iodide (PI) have been carried out in order to ascertain their mode of action. The observed results indicated that the major cause of cancer cell death is apoptosis, but a minor role played by necrosis cannot be excluded. It is concluded on the basis of the observed results that the nature and number of organic groups bonded to tin as well as the nature of counter anions play an important role in determining the cytotoxicity of organotin(IV) compounds. 相似文献
55.
56.
Dr. Anna Notaro Marta Jakubaszek Severin Koch Dr. Riccardo Rubbiani Dr. Orsolya Dömötör Dr. Éva A. Enyedy Mazzarine Dotou Dr. Fethi Bedioui Mickaël Tharaud Dr. Bruno Goud PD Dr. Stefano Ferrari Prof. Dr. Enzo Alessio Dr. Gilles Gasser 《Chemistry (Weinheim an der Bergstrasse, Germany)》2020,26(22):4997-5009
Cancer is one of the main causes of death worldwide. Chemotherapy, despite its severe side effects, is to date one of the leading strategies against cancer. Metal-based drugs present several potential advantages when compared to organic compounds and they have gained trust from the scientific community after the approval on the market of the drug cisplatin. Recently, we reported the ruthenium complex ([Ru(DIP)2(sq)](PF6) (where DIP is 4,7-diphenyl-1,10-phenantroline and sq is semiquinonate) with a remarkable potential as chemotherapeutic agent against cancer, both in vitro and in vivo. In this work, we analyse a structurally similar compound, namely [Ru(DIP)2(mal)](PF6), carrying the flavour-enhancing agent approved by the FDA, maltol (mal). To possess an FDA approved ligand is crucial for a complex, whose mechanism of action might include ligand exchange. Herein, we describe the synthesis and characterisation of [Ru(DIP)2(mal)](PF6), its stability in solutions and under conditions that resemble the physiological ones, and its in-depth biological investigation. Cytotoxicity tests on different cell lines in 2D model and on HeLa MultiCellular Tumour Spheroids (MCTS) demonstrated that our compound has higher activity than cisplatin, inspiring further tests. [Ru(DIP)2(mal)](PF6) was efficiently internalised by HeLa cells through a passive transport mechanism and severely affected the mitochondrial metabolism. 相似文献
57.
Andreea L. Turcu Antoine Versini Nadjib Khene Christine Gaillet Dr. Tatiana Cañeque Dr. Sebastian Müller Dr. Raphaël Rodriguez 《Chemistry (Weinheim an der Bergstrasse, Germany)》2020,26(33):7369-7373
Cancer stem cells (CSC) constitute a cell subpopulation in solid tumors that is responsible for resistance to conventional chemotherapy, metastasis and cancer relapse. The natural product Salinomycin can selectively target this cell niche by directly interacting with lysosomal iron, taking advantage of upregulated iron homeostasis in CSC. Here, inhibitors of the divalent metal transporter 1 (DMT1) have been identified that selectively target CSC by blocking lysosomal iron translocation. This leads to lysosomal iron accumulation, production of reactive oxygen species and cell death with features of ferroptosis. DMT1 inhibitors selectively target CSC in primary cancer cells and circulating tumor cells, demonstrating the physiological relevance of this strategy. Taken together, this opens up opportunities to tackle unmet needs in anti-cancer therapy. 相似文献
58.
Raana Kashfi‐Sadabad Laura Gonzalez‐Fajardo Derek Hargrove Bahar Ahmadi Daniel Munteanu Sina Shahbazmohamadi Michael Jay Xiuling Lu 《Particle & Particle Systems Characterization》2019,36(4)
Nonspecific high‐energy radiation for treatment of metastatic ovarian cancer is limited by damage to healthy organs, which can be mitigated by the use of radiosensitizers and image‐guided radiotherapy. Gold (Au) and tantalum oxide (TaOx) nanoparticles (NPs), by virtue of their high atomic numbers, find utility in the design of bimetallic NP systems capable of high‐contrast computed tomography (CT) imaging as well as a potential radiosensitizing effect. These two radio‐dense metals are integrated into dendritic mesoporous silica NPs (dMSNs) with radial porous channels for high surface‐area loading of therapeutic agents. This approach results in stable, monodispersed dMSNs with a uniform distribution of Au on the surface and TaOx in the core that exhibits CT attenuation up to seven times greater than iodine or monometallic dMSNs without either TaOx or Au. Tumor targeting is assessed in a metastatic ovarian cancer mouse model. Ex vivo micro‐CT imaging of collected tumors shows that these NPs not only accumulate at tumor sites but also penetrate inside tumor tissues. This study demonstrates that after intraperitoneal administration, rationally designed bimetallic NPs can simultaneously serve as targeted contrast agents for imaging tumors and to enhance radiation therapy in metastatic ovarian cancer. 相似文献
59.
Thies Dirksmeyer Paul Stahl Dr. Cecilia Vallet Prof. Dr. Shirley Knauer Prof. Dr. Michael Giese Prof. Dr. Carsten Schmuck Dr. Christoph Hirschhäuser 《Chemistry (Weinheim an der Bergstrasse, Germany)》2022,28(43):e202104618
A transfection vector that can home in on tumors is reported. Whereas previous vectors that allow moderately cell selective gene transfection used larger systems, this small-molecule approach paved the way for precise structure-activity relationship optimization. For this, biotin, which mediates cell selectivity, was combined with the potent DNA-binding motif tetralysine-guanidinocarbonypyrrol via a hydrophilic linker, thus enabling SAR-based optimization. The new vector mediated biotin receptor (BR)-selective transfection of cell lines with different BR expression levels. Computer-based analyses of microscopy images revealed a preference of one order of magnitude for the BR-positive cell lines over the BR-negative controls. 相似文献
60.
Discovery,Characterization, and Analogue Synthesis of Bohemamine Dimers Generated by Non‐enzymatic Biosynthesis 下载免费PDF全文
Dr. Peng Fu Aaron Legako Scott La Prof. Dr. John B. MacMillan 《Chemistry (Weinheim an der Bergstrasse, Germany)》2016,22(10):3491-3495
Dibohemamines A–C ( 5 – 7 ), three new dimeric bohemamine analogues dimerized through a methylene group, were isolated from a marine‐derived Streptomyces spinoverrucosus. The structures determined by spectroscopic analysis were confirmed through the semi‐synthetic derivatization of monomeric bohemamines and formaldehyde. These reactions, which could occur under mild conditions, together with the detection of formaldehyde in the culture, revealed that this dimerization is a non‐enzymatic process. In addition to the unique dimerization of the dibohemamines, dibohemamines B and C were found to have nm cytotoxicity against the non‐small cell‐lung cancer cell line A549. In view of the potent cytotoxicity of compounds 6 and 7 , a small library of bohemamine analogues was generated for biological evaluation by utilizing a series of aryl and alkyl aldehydes. 相似文献